TGF-β promotes PI3K-AKT signaling and prostate cancer cell migration through the TRAF6-mediated ubiquitylation of p85α
Male
Mice, Knockout
TNF Receptor-Associated Factor 6
0301 basic medicine
Lysine
Receptor, Transforming Growth Factor-beta Type I
Prostatic Neoplasms
Apoptosis
Fibroblasts
Protein Serine-Threonine Kinases
Embryo, Mammalian
3. Good health
Class Ia Phosphatidylinositol 3-Kinase
Mice
03 medical and health sciences
Cell Movement
Animals
Humans
Phosphorylation
Proto-Oncogene Proteins c-akt
Receptors, Transforming Growth Factor beta
Cells, Cultured
Signal Transduction
DOI:
10.1126/scisignal.aal4186
Publication Date:
2017-10-05T20:05:21Z
AUTHORS (8)
ABSTRACT
Transforming growth factor-β (TGF-β) is a pluripotent cytokine that regulates cell fate and plasticity in normal tissues tumors. The multifunctional cellular responses evoked by TGF-β are mediated the canonical SMAD pathway noncanonical pathways, including mitogen-activated protein kinase (MAPK) pathways phosphatidylinositol 3'-kinase (PI3K)-protein B (AKT) pathway. We found activated PI3K manner dependent on activity of E3 ubiquitin ligase tumor necrosis factor receptor-associated 6 (TRAF6). TRAF6 polyubiquitylated regulatory subunit p85α promoted formation complex between type I receptor (TβRI) p85α, which led to activation AKT. Lys63-linked polyubiquitylation Lys513 Lys519 iSH2 (inter-Src homology 2) domain was required for TGF-β-induced PI3K-AKT signaling motility prostate cancer cells macrophages. Unlike TRAF6-mediated AKT not TβRI. In situ proximity ligation assays revealed evident aggressive tissues. Thus, our data reveal molecular mechanism activates drive migration.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (59)
CITATIONS (167)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....